Irinotecan Hydrochloride Injection USP 20 mg

Irinotecan Hydrochloride Injection USP 20 mg is a cancer treatment medication used to slow or stop cancer cell growth. This intravenous solution is manufactured by Accord Healthcare Inc. in Canada.

Irinotecan Hydrochloride Injection is primarily used in cancer treatment, specifically for colorectal cancer. It works by interfering with the growth and spread of cancer cells. This medication is often part of a combination therapy to enhance treatment effectiveness. Patients should consult their healthcare provider to understand what Irinotecan Hydrochloride is used for in their specific case.

Common effects of Irinotecan Hydrochloride Injection may include nausea, vomiting, diarrhea, and fatigue. Some patients may experience hair loss or changes in blood cell counts. These effects can vary in severity and duration. Always discuss any concerns with a healthcare professional.

Irinotecan Hydrochloride Injection should be handled with care, as it is a potent medication. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored and administered under proper medical supervision to ensure safety.

Irinotecan Hydrochloride Injection may interact with other medications, including those that affect the liver or blood cell counts. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.